ArticleNPJ precision oncology2023

Biology-aware mutation-based deep learning for outcome prediction of cancer immunotherapy with immune checkpoint inhibitors.

Junyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.